SidneyMallenbaumMDFAHA, FAANEM

Clinical Trials

• A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator) Start of enrollment: 2000 Dec 01

  Completed

  Phase 2

• A Study to Evaluate the Effects of YM872 on Stroke Lesion Volume in Acute Stroke Patients Start of enrollment: 2000 Dec 01

  Completed

  Phase 2

• Safety of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke Start of enrollment: 2004 Aug 01

  Completed

  Phase 2

• Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke Start of enrollment: 2003 Jun 01

  Completed

  Phase 3

• Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke (SENTIS) Start of enrollment: 2005 Jun 01

  Completed

  Phase 3

• Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke Start of enrollment: 2005 Sep 01

  Terminated

  Phase 3

• Albumin in Acute Ischemic Stroke Trial Start of enrollment: 2006 Jun 01

  Terminated

  Phase 3

• Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI) Start of enrollment: 2004 Sep 01

  Terminated

  Phase 2

• ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke Start of enrollment: 2006 Mar 01

  Terminated

  Phase 3

• Effectiveness and Safety Trial of a New Ischemic Stroke Treatment Within 24 Hours From Stroke Onset (NEST-2) Start of enrollment: 2006 Dec 01

  Completed

  Phase 3

• GORE® Septal Occluder Device for Patent Foramen Ovale (PFO) Closure in Stroke Patients Start of enrollment: 2008 Dec 10

  Completed

  Not Applicable

• Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke Start of enrollment: 2009 Dec 01

  Terminated

  Phase 3

• Efficacy and Safety Trial of Transcranial Laser Therapy Within 24 Hours From Stroke Onset (NEST-3) Start of enrollment: 2010 Sep 01

  Completed

  Phase 3

• [SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES] Start of enrollment: 2014 Jan 07

  Completed

  Phase 3

• Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS) Start of enrollment: 2014 Nov 27

  Completed

  Phase 3

• Join now to see all